| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b058139d52d0c9a4409d9a5f7fedd21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate |
1993-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_389abaa599b253d3f00dad7d82c78625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e33d3fa2f2428a5487f8a86cdd26efef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_519704f6977611b333eac237de5c0962 |
| publicationDate |
1993-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0562705-A1 |
| titleOfInvention |
Use of L-deprenyl for the manufacture of a medicament for the treatment of Cushing's Disease |
| abstract |
A method of treating Cushing's Disease comprising treating mammals, and especially humans, dogs, horses or ponies with from 0.01 to about 4.0 mg/kg of body weight of L-Deprenyl, preferably daily, to achieve and maintain remission. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1081918-C |
| priorityDate |
1992-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |